Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
Saved in:
| Title: | Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features. |
|---|---|
| Authors: | Sloan EA; Department of Pathology, University of California, San Francisco, CA, USA., Hilz S; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Gupta R; Department of Pathology, University of California, San Francisco, CA, USA., Cadwell C; Department of Pathology, University of California, San Francisco, CA, USA., Ramani B; Department of Pathology, University of California, San Francisco, CA, USA., Hofmann J; Department of Pathology, University of California, San Francisco, CA, USA., Kline CN; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, CA, USA., Banerjee A; Department of Neurological Surgery, University of California, San Francisco, CA, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, CA, USA., Reddy A; Department of Neurological Surgery, University of California, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, CA, USA., Oberheim Bush NA; Department of Neurology, University of California, San Francisco, CA, USA.; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA, USA., Chang S; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA, USA., Braunstein S; Department of Radiation Oncology, University of California, San Francisco, CA, USA., Chang EF; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Raffel C; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Gupta N; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Sun PP; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Kim JYH; Department of Pediatric Neurosurgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA., Moes G; Department of Pathology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA., Alva E; Division of Hematology and Oncology, Children's of Alabama, University of Alabama at Birmingham, Birmingham, AL, USA., Li R; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA., Bruggers CS; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA., Alashari M; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Wetmore C; Department of Hematology/Oncology, Phoenix Children's Hospital, Phoenix, AZ, USA., Garg S; Department of Pathology, Phoenix Children's Hospital, Phoenix, AZ, USA., Dishop M; Department of Pathology, Phoenix Children's Hospital, Phoenix, AZ, USA., Van Ziffle J; Department of Pathology, University of California, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA, USA., Onodera C; Department of Pathology, University of California, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA, USA., Devine P; Department of Pathology, University of California, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA, USA., Grenert JP; Department of Pathology, University of California, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA, USA., Lee JC; Department of Pathology, University of California, San Francisco, CA, USA., Phillips JJ; Department of Pathology, University of California, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Pekmezci M; Department of Pathology, University of California, San Francisco, CA, USA., Tihan T; Department of Pathology, University of California, San Francisco, CA, USA., Bollen AW; Department of Pathology, University of California, San Francisco, CA, USA., Berger MS; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Costello JF; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Perry A; Department of Pathology, University of California, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Solomon DA; Department of Pathology, University of California, San Francisco, CA, USA. david.solomon@ucsf.edu.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA, USA. david.solomon@ucsf.edu. |
| Source: | Acta neuropathologica [Acta Neuropathol] 2020 May; Vol. 139 (5), pp. 953-957. Date of Electronic Publication: 2020 Mar 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0533 |
|---|---|
| DOI: | 10.1007/s00401-020-02144-8 |
